NR1H4 and metabolic dysfunction-associated steatotic liver disease: In more detail, in NAFLD patients there is an increase in plasma levels of bile acids and a reduction in hepatic FXR levels, with the greater expression of SREBP-1C and hepatic triglyceride synthesis [50].